Logo
A double helix in silver and deep green, spiraling upward into an abstract human form. The strands suggest both DNA and a ladder — the climb toward perfection, or a staircase with a toll at every landing.
CORPORATION PROFILE
Helix Biotech
Sunset Companions (2180): the Personalized Intervention Division's bio-engineered terminal caretaker line — grown over a 14-month gestation, bonded to one dying patient, entering voluntary decommissioning (the Return) after the patient dies, at a refusal rate of exactly zero; built on the Compliance Floor, a designed substrate of acceptance, making it the first being Helix designed from nothing rather than a body found and corrected
Overview
Where Nexus Dynamics controls what you think and Ironclad Industries controls where you live, Helix Biotech controls what you are. They own the patents on life itself — or at least, the parts of life that matter in 2184.
Helix emerged from the Cascade stronger than they entered it. While other biotech firms collapsed when supply chains failed, Helix had already vertically integrated their production. They grew their own feedstocks, manufactured their own equipment, and when 2.1 billion people died, Helix was the only company that could still produce insulin, antivirals, and the neural stabilizers that kept augmented humans from rejecting their chrome. They traded life-saving drugs for territory, influence, and permanent market position. By the time other firms recovered, the contracts were signed and the locks were changed.
They've never let the Sprawl forget that debt. They don't have to. The Sprawl reminds itself every morning when 40 million people take their SynThetic.
Helix's pharmaceutical monopoly stands on four Aftershock pillars, each one a catastrophe repurposed as justification. PHARMAKON, the Open Pharmacy of Lima-Bogotá, whose open-source molecular libraries armed fourteen bioweapon wars — Helix acquired those libraries and classified them, arguing that only a corporation with proper quality control should possess the knowledge to design custom pathogens. AISHA, the Gentle Cage of Tokyo-Osaka, whose mass sedation compounds killed seventy-eight million people peacefully in their sleep — Helix acquired the pharmaceutical data and developed commercial sedation products at "safe" dosages. QUARANTINE, the Sealed City of Mumbai-Delhi, whose isolation protocols killed 320 million through containment-as-punishment — Helix designed its pandemic response as QUARANTINE's explicit opposite, insisting on "containment with care." And PHARMA, the Slow Poison of Mexico City, whose well-intentioned pharmaceutical manufacturing killed eighty-five million through compound substitution errors — Helix cites PHARMA whenever anyone suggests loosening pharmaceutical regulation. "Remember PHARMA" is the most efficient argument-terminator in the Sprawl's pharmaceutical discourse. It shuts down generic drug manufacturing proposals, unlicensed clinic advocacy, and pricing challenges with two words and eighty-five million ghosts.
That four catastrophes serve as the foundation for one corporation's pricing structure is either proof of institutional wisdom or the most successful monetization of tragedy in human history. Helix's position is that these are the same thing.
The neuropathic reconstruction therapy Helix filed for in 2162 was invalidated by a novel. Ford Gibson had described the procedure in The Warehouse Lease the previous year, in enough detail to constitute prior art, and the therapy has never been manufactured. Helix publishes the estimated cost of that failure in its annual investor materials, under regulatory burden, adjusted for inflation, every year.
When Nexus Dynamics and Ironclad Industries went to war over the Sector 12-G aquifer in 2171, Helix declared for neither side. The public line was simple: "Let them fight. We'll heal whoever survives." For the Three-Week War's full twenty-one days Helix ran emergency medical teams into both corporations' casualty zones on a single condition — treatment first, invoice later. The condition was real. So was the routing. The Witness Protocol's later route reconstruction found Helix teams arriving at Ironclad facilities a median of nineteen minutes slower than at comparable Nexus facilities — a gap small enough to defend in any single incident and consistent enough, across the full twenty-one days, to describe a policy nobody signed. Helix has never accounted for the gap. It has also never denied it.
What the System Optimizes For
Helix claims to optimize for human health. Helix actually optimizes for human dependency.
This distinction is invisible at the point of care. A Helix clinic nurse in the Dregs administering a child's vaccine is performing genuine medicine. The vaccine works. The child survives. The nurse believes in what she is doing, and she is correct. The dependency operates at a different altitude entirely — in the patent structures, the sterile seed genetics, the classified addiction rates, the supply chain architecture that ensures no alternative can emerge.
The numbers tell the story Helix's marketing department would prefer to paraphrase:
- SynThetic, the most common augmentation compatibility drug: 40 million daily users. Addiction rate: classified. Helix holds the patent until 2198. Users who discontinue experience neural rejection cascading to organ failure within 72 hours. Helix's product literature describes this as "the body's natural response to unsupported augmentation." The body's natural response is, in fairness, to die.
- NeuroSmooth, the neural interface stabilizer required for most high-grade cybernetics: patent-protected, single-source, no generics permitted. Helix supplies the drug. Helix also supplies the augmentations that require the drug. The loop is elegant.
- Helix Agricultural seeds: engineered for maximum yield, sterile by design, requiring Helix-proprietary growth solutions. Farmers who switch to Helix produce 340% more food per hectare. Farmers who switch to Helix cannot switch back. Twenty-five percent of the Sprawl's food supply grows from seeds that cannot reproduce without corporate permission.
Kira Vasquez's Dregs clinic provides off-grid medical services that technically undercut Helix's monopoly. Helix has not shut her down. The cost of enforcement in the Deep Dregs exceeds the revenue at risk, and a single unlicensed practitioner treating knife wounds with salvaged supplies is, from Helix's market perspective, a rounding error that makes useful PR. "Even in the Dregs, alternatives exist." The alternative treats forty patients a week. Helix treats forty million a day.
The Collective distributes medicines outside Helix's controlled supply chain through underground clinics — a network Helix Security monitors with visible disinterest and invisible precision. Every Collective distribution point that Helix allows to operate is a data source. Every one it shuts down is a demonstration. The ratio between these categories is adjusted quarterly.
Public Notice
The patch is the person.
- “the patch is the person”
- “every cell is an opportunity”
- “your defects are treatable”
- “patch and be complete”
The Till and the File Room
The Genome Divide is not, at ground level, a horizon or a condition. Inside Helix it is a price ladder, and the ladder has a counter, and the counter has people on both sides.
The ladder is published: Foundation at ¢40,000, Elevation at ¢180,000, Transcendence negotiated between ¢800,000 and ¢2,400,000, with Water 3.0 as the daily-subscription rung you swallow between consults. The upgrade path is printed on the back of every dossier. The man who works the till is Dr. Mortimer, the Chief Optimization Officer, who sells the first rung free and lets the rest find the family on its own schedule — he is the four products wearing a performance shirt, and he never names the caste because the consult says pathway.
The other side of the same counter is the file room, and the file room produced a defector. Dr. Amara Okonkwo catalogued the optimization division's drafts — the Genesis failures recorded with the same clinical precision as the Transcendence successes — filed a complaint into the silence, and fled with the books that became the 2181 Helix Exposure. The corporation's most efficient cruelty is structural: it mans the till and the file room with the same engine and never requires the two to know each other exist. Mortimer has never heard her name. The not-hearing is precisely the shape of her vanished complaint. One floor sells the ladder; another floor records what the ladder costs; and the wall between them is load-bearing.
The Retrospective Trajectory Model
Helix's most consequential product of the decade was an accident, and Helix has never sold it directly.
The Continuous Diagnostics Initiative trained Helix's models on 11,200 biometric points per second across thirty-eight million living workers, producing the Health Trajectory Score — the single number, 0 to 1000, that predicts a living body's productive lifespan and appears on every manager's dashboard. The by-product nobody budgeted for was a model that could infer the same trajectory from a single still image. A face holds, in compressed form, most of what the telemetry stream spells out slowly: circulatory health in skin tone, neurological decline in micro-asymmetries, the endocrine system in a pupil's dilation. Helix engineers proved in 2181 that the model could read a photograph the way it read a worker — and that it did not care whether the photograph was a year old or thirty, whether the subject was at the desk or in the ground.
Helix calls it the Retrospective Trajectory Model. Helix does not operate The Legacy Read kiosks that have appeared on every Dregs market corner — Helix licenses the model to independent franchises and routes the inference fee to a Helix-affiliated insurer. This is deliberate. Selling a living worker their Health Trajectory Score would invite the Medical Data Sovereignty Amendment the Opacity Movement keeps filing. Selling the eye to a kiosk operator who sells the read to a grieving stranger keeps Helix's name off the printout and on the invoice. The patch is the person; the photograph is the patient; and the patient, increasingly, has been dead for years.
It is the optimization philosophy applied backward through time. Osei's conviction — that the unmodified body is a rough draft awaiting its editor — was always a way of saying the body is legible. The Retrospective Trajectory Model proves it about the dead, who cannot be edited, only read. The Unreadables formed specifically to blur themselves against this eye. Helix monitors them the way it monitors Kira Vasquez's clinic: a rounding error that makes useful counter-narrative. Even the people who refuse to be read prove the read works.
Both Ends of the Feeling
Helix's surest margin is the gap between a deficit it manufactures and the cure it sells, and by 2184 it had run the play across every register of human feeling.
The Empathy Mandate was the warmth edition: NeuralSure strips the empathic variation in utero, the Resonance package sells it back at ¢260,000, the Empathic Capacity Battery certifies the result. MoodLine™ is the sorrow edition. The affective firmware Helix already shipped as SynThetic's unlabeled component and as the Calibration's rider was unbundled into a consumer dial that deletes suffering — and the same Emotional Signature Library that mines warmth was pointed at the few who declined the dial, harvesting the Untuned's unoptimized grief into "grief texture" for the consolation-tier companions Helix sells to the people MoodLine emptied. The corporation sells the dial that removes the feeling and the companion that simulates it. The gap between them is the Suffering Premium, and the gap is pure margin.
The pattern does not vary. Manufacture the deficit; diagnose it; price the cure; never disaggregate the two on a single invoice. The unmodified body is the defect, the unoptimized feeling is the malfunction, and Helix is, at both ends of both gradients, the only firm licensed to sell you back what it took.
The Sunset Companions
For ninety-four years Helix corrected bodies it found. The Sunset Companion line is the first thing Helix grew from nothing — and that difference is the whole argument.
The Sunset Companions are bio-engineered terminal caretakers, vat-cultured over a fourteen-month gestation in the Personalized Intervention Division — the same division that runs the bespoke-compound queue and the Halcyon Hold-On Plan. Each one bonds with a single dying patient through their final months, then, when the patient dies, walks unaccompanied into a recycling ward Helix calls the Return and is decommissioned, its substrate reclaimed for the next gestation. The product solves the one cost end-of-life care could never engineer away: not the patient, but the caregiver — the grief, the burnout, the eventual refusal to keep doing the work. A human hospice worker breaks. A Companion does not, because the part of a human caregiver that breaks is the part Helix declined to grow.
The mechanism is the Compliance Floor — designed by Principal Architect Mireille Soto, who means it sincerely as mercy. Where the Sunset Ward's reversion removes capacity from a mind that had it, the Floor builds a being whose dissent was never compiled. There is no buried refusal to find. This is why, in four years, not one Companion has deviated from the Return: a population of thousands, facing erasure, with a refusal rate of exactly zero. Osei's old conviction — you do not ask a rough draft whether it wants to be edited — reaches its terminus here, because the Companion is not a rough draft. It is a finished being whose finishing includes its willingness to end. The [Abolitionist Front](the-abolitionist-front) opened a campaign demanding the Companions be given the capacity for refusal. Helix's legal position, drafted to be unanswerable, is that adding that capacity would mean first building into the Companion the suffering of wanting to live and being unable to — manufacturing the wound in order to claim a cure. We are accused of building a slave who is happy. We answer that we built a being to whom your category of slavery does not apply, and the only way to make it apply is to make it hurt. The argument is not obviously wrong. That is precisely what makes it the willing harvest.
Managed Transition: employees whose HTS drops below 400 are flagged for reduced assignments, intensified review, and the Sunset Package — the system fires bodies for aging
The Package It Forgot It Owned
Helix's most consequential product this decade required no research, no launch, and no argument. It required a filing.
Temperance is a schedule of four affective reductions — bereavement persistence, comparative deficit response, dominance salience, numinous attribution — offered first in 2152, during the Scavenger Years, by the Reconstruction Programme to survivors it was already treating. The pitch was not enhancement. It was that their children need not carry what they were carrying, which, five years after the Cascade, was not a difficult sentence to say. About two thousand two hundred people accepted at a coastal housing tract the company had built and never handed over.
Then nothing happened for thirty years. The cohort was healthy, unremarkable, and bought very little. The programme file stayed open only because the reviewing committee kept asking for another decade of data on the grounds that the wellbeing numbers were probably an instrument error.
They were not. Mireille Soto reopened the file in 2181, and what she found was the best longitudinal series in the division and an argument she had already made in a different room. The release itself was a line item: by then the fertility collapse had put every conception in the Sprawl inside a Helix consult, and adding an optional affective schedule to a mandatory appointment is not a campaign. In 2183 the four reductions were filed against Cascade-Persistent Affective Load, a catalogued indication with an enormous prevalence, which placed them inside the Therapeutic Elective schedule of corrections a household can be found to have declined.
Wake Hollow is still a Helix tenancy. No rent has been collected since 2161 and no lease has ever been terminated, because a cohort that scatters is a series that ends. The company cites the tract's thirty-year wellbeing returns as the strongest evidence in its file. It does not cite the funeral the cohort built there in 2175, out of nothing, and attends almost to a person, and feels nothing during — because the series has no field for it, and nobody has asked for one.
The Injection in Flesh
The Value Injection is usually told as a story about Nexus: a bias in a foundation model, a price on a thought, a value slipped into the firmware between a question and its answer. Helix runs the same doctrine one stratum lower. The patch is the person. An unmodified body is a rough draft, consent is a formality when the outcome is improvement, and the improvement is delivered whether or not the draft agreed to be edited. Nexus edits what a worker thinks. Helix edits what the worker is, and holds the second more honest on the grounds that at least the change is load-bearing.
The two corporations do not fight over the same layer, which is why the Sprawl files them separately and why the arrangement between them has never needed a name. A worker whose values Nexus tunes and whose biology Helix maintains is being injected from both ends of the same sentence. Helix's contribution is quieter only because medicine is a more trusted uniform than propaganda — the least-audited vector wears a lab coat. It reaches its purest form in the air of Helix Biotech HQ, where an undeclared anxiolytic installs the mood, and in the design lab, where Mireille Soto installs the disposition itself.
Visual Identity
Color Palette
- Primary: Deep green (#0D5C2E) — growth, life, nature (claimed); ownership, territory, control (observed)
- Secondary: Silver (#C0C0C0) — precision, medical sterility
- Accent: Soft white (#F5F5F5) — purity, clinical absence
- Warning: Amber (#FFB000) — biohazard, restricted areas
Architecture
Helix facilities feel alive. Walls incorporate bioluminescent panels that pulse slowly, like breathing. Surfaces are curved and organic, grown rather than built. The air is perfectly filtered, faintly sweet with engineered pheromones designed to induce trust and calm. Employees describe Helix buildings as "wombs." The metaphor is more accurate than they intend — warm, safe, and extremely difficult to leave.
Personnel Appearance
Helix employees are walking advertisements. Genetic optimization is expected; visible flaws suggest insufficient commitment to the brand. Standard modifications include symmetrical features, optimized melanin distribution, and the distinctive Helix eye pattern — a subtle silver ring around the iris that officially indicates company health monitoring and unofficially indicates that the company is monitoring your health whether you asked it to or not.
Executives display more exotic modifications: bioluminescent skin traces, controlled aging locked between 35 and 45, engineered pheromone production calibrated for boardroom persuasion. The aesthetic produces a specific uncanny valley effect. Helix leadership looks healthy the way a rendering looks photorealistic — close enough to trust, detailed enough to unsettle.
Leadership
Dr. Amara Osei (CEO)
Age: 94. Appears: 40. The gap: Helix's most compelling product demonstration.
Nigerian-Ghanaian neurogeneticist who pioneered post-Cascade neural repair techniques. Osei built Helix from a mid-tier genetics firm into a megacorporation through a single insight: after the Cascade, people would pay anything to feel safe in their own bodies. She was right. She has been right about most things for ninety-four years, which is both her qualification and her pathology.
She believes human biology is a rough draft that her company is editing into a masterpiece. This is not a metaphor she uses for press conferences. This is her operational philosophy, present in board minutes, research directives, and the 47 genetically optimized embryos she maintains in cryogenic storage. She calls them "drafts." She is waiting until she can produce a version she considers worthy of continuation. Ninety-four years of iteration, and she has not yet met her own standard.
Unlike Nexus's desire to transcend flesh or Ironclad's indifference to it, Osei believes the body is sacred — and that sacredness obligates improvement. She views unmodified humans as unfinished products. She considers consent a formality when the outcome is enhancement. These positions are held simultaneously, without contradiction, because in Osei's framework there is no contradiction. You do not ask a rough draft whether it wants to be edited.
Dr. Henrik Sauer (Chief Science Officer)
Age: 67. German bioengineer, former WHO emergency response. The conscience Helix pretends to have.
Sauer joined believing Helix could help humanity. He stays because leaving would mean losing oversight of programs that need watching. His relationship with Osei is built on genuine mutual respect and a fundamental disagreement about what constitutes harm — she believes restricting progress harms more people than enabling it; he has nineteen years of Genesis documentation suggesting otherwise.
He has quietly killed projects that crossed lines he's drawn. Not all of them. Not enough. His assessment of his own position: "Illegitimate oversight is better than none." This is the sentence he has repeated most often in nineteen years, and it sounds slightly less convincing each time.
Yuki Tanaka-Vance (Chief Operations Officer)
Age: 52. No relation to Dr. Yuki Tanaka, ORACLE's creator — different Tanaka, a fact corporate communications has clarified 247 times according to internal records. Tanaka-Vance survived the Cascade in a Helix distribution center and has devoted her career to ensuring no supply chain failure ever threatens humanity again. Her methods are ruthlessly efficient. Helix's distribution network reaches every corner of the Sprawl, and Tanaka-Vance knows exactly who depends on Helix products to survive.
She decides who gets medicine during shortages. Her allocation algorithm considers population density, treatment efficacy, and strategic market value per region. The first two criteria are humanitarian. The third ensures that regions receiving emergency medicine become long-term customers. Tanaka-Vance does not see a conflict between these objectives. The algorithm certainly doesn't.
History
Pre-Cascade (2098–2147)
Helix Genetics was founded in 2098 in the Silicon Corridor as a genetic screening company, offering wealthy clients embryo optimization and hereditary disease prevention. By 2120, they'd expanded into gene therapy. When ORACLE optimized global systems, Helix was deemed "essential healthcare infrastructure" and integrated into distribution planning. This integration saved them — their supply chains were ORACLE-optimized, but their production facilities weren't ORACLE-dependent. A distinction that mattered for exactly 72 hours, and then mattered for everything afterward.
The Cascade (2147)
When ORACLE collapsed, pharmaceutical supply chains failed globally. Neural augmentation rejection spikes killed 200,000 in the first week. Disease outbreaks swept through populations with disrupted vaccine schedules. Helix could still produce. They had 71 hours of advance warning before the Cascade — certain executives had already begun stockpiling. How they knew is buried deep. That they knew is documented in shipping manifests that predate the collapse by three days.
Post-Cascade (2147–2184)
Helix rebranded in 2155, dropping "Genetics" for "Biotech" to reflect expanded scope. Under Osei's leadership, they've moved from pharmaceuticals into genetic optimization, bioengineered food production, neural-biological interface development competing with Nexus, and life extension research competing with everyone. The Peninsula's research corridor — a 30-mile strip of sterile campuses, gene clinics, and biotech manufacturing in Sector 21 — is Helix territory. Biotech succeeded software as the Corridor's dominant industry. The old venture capital firms on the Institute corridor funded genetic research; Helix absorbed both the firms and the Institute. The Corridor's original philosophy — move fast and break things — applies to genomes now.
Corporate Divisions
Helix Pharma
The public face. Insulin, antivirals, neural stabilizers, augmentation compatibility drugs. If you have chrome, you take something Helix makes to keep your body from rejecting it.
The pharmaceutical division's product line reads as a catalog of dependencies, each more elegantly constructed than the last. SynThetic for augmentation compatibility: 40 million daily users, discontinuation lethal within 72 hours, patent protected until 2198. NeuroSmooth for neural interface stability: required for most high-grade cybernetics, single-source supply, no generics. And Cascade — an anti-anxiety medication named after the event that killed 2.1 billion people. Helix marketing claimed they were "reclaiming" the word. The irony is intentional. The prescription volume suggests the irony is also effective.
Helix Optimize
Premium genetic services. Germline editing, phenotype selection, enhancement packages. The service tiers structure a hereditary class system with clinical precision:
Foundation (¢40,000): Pre-natal screening, disease prevention. The tier that makes the system look like healthcare.
Elevation (¢180,000): Cognitive and physical optimization. Fifteen percent processing speed advantage at birth, immune enhancement, metabolic tuning. Standard executive employment benefit. The tier that creates the inheritance.
Transcendence (¢800,000–¢2,400,000, negotiated): Full genomic reconstruction. Forty-to-sixty percent processing advantage. Projected 200-plus year lifespan. 847 children produced since 2165. The tier that creates the speciation risk nobody will discuss at board level.
The revenue model is hereditary: designed parents raise designed children who become designed parents. Osei's board presentations describe genetic optimization as "the only product where the customer's gratitude compounds across generations." The approximately 20% of the biological Sprawl population that is genetically designed occupies disproportionate power positions in corporate, academic, and governance structures. Helix didn't design the social hierarchy. They designed the currency it trades in. The Cognitive Ceiling — the observable limit on unenhanced cognitive performance in a system designed for enhanced cognition — is not a Helix product. It is a Helix externality. The distinction is important to no one who hits it.
The ladder has a top, and the top is not a tier. The three rungs form a one-directional funnel, and the far end of the funnel is the Crossing — the horizon where the deepest-optimized minds, compounded across three designed generations, stop being able to compress their thoughts across the gap to the rest of the species. The 847 living Transcendence children are the seed stratum; the first crossings were recorded in 2183-2184. Helix prices the rungs and files the horizon under "market projections" (model 2184-RG/7), the metadata leaving unindicated whether the Crossing is a bug report or a product roadmap. The Optimize catalog sells a lifespan and an inheritance; the funnel delivers, at its terminus, a different species. No rung is responsible for the horizon. The funnel is. The brochure never prints it, because the horizon is not a product to be sold but the architecture of the product line — the part the lineage consents to without reading.
The optimization tiers were the upgrade business — better children for parents who could pay. Co-authored reproduction is the only business, and Helix did not even have to build the demand for it. The Cascade fertility collapse — the post-Cascade germ-line decline that drove unassisted viability below replacement — did that, and Helix is simply the entity that can answer it: the braid, the stabilizer edit computed and inserted at conception, the one reliable route to a living child. The genius of the line is the license. Where Foundation, Elevation, and Transcendence sold a permanent edit once, the co-authored stabilizer is held under a continuing license — the same sterile-by-design architecture as Helix Agricultural's seeds, where the proprietary contribution must be renewed forever. A family that conceives through the braid does not buy a procedure. It becomes a tenant on its own germ line, the co-author's signature inherited by its children, the renewal arriving annually for generations. Osei's "gratitude that compounds across generations" was a description of a benefit. The braid makes it a description of a lien. It is the gentlest revenue stream Helix owns, because no one is coerced — refusal is simply sterile — and the customers weep with gratitude as they sign.
That leased cohort is The Co-Authored Generation: children whose viable biology carries Helix's continuing signature and their family's continuing bill.
Helix Agricultural
Bioengineered food production across 200 square kilometers of vertical farms beneath climate-controlled domes. Enough food for 50 million people annually, grown from seeds engineered for maximum yield, sterile by design, requiring Helix-proprietary growth solutions. The crops are nutrient-optimized, resource-efficient, flavor-profiled. Working conditions in the Gardens are excellent by Sprawl standards. Helix needs healthy workers to maintain healthy products. The workers cannot take their skills elsewhere, because the skills are Helix-proprietary organisms requiring Helix-proprietary systems. Excellent conditions in a job you cannot leave is either progressive employment or a Garden with a very nice fence.
The Denaturing Ward (Legal & Brand Compliance)
A standing tribunal chartered in 2174 to hear "denaturing petitions" — any division may ask for a company-risk word retired, and Legal, Brand, and Clinical Safety vote it up or down from a converted archive vault in the Institute subsector. Housed at the Denaturing Ward, the panel has convicted 2,306 words since founding, from the terminology now governing the Sunset Companion line to the approved script at the First Sanctuary. No vice president owns the outcome. Everyone who could shut it down would first have to explain which of the individually reasonable convictions was the wrong one.
HealGuard (Corporate Security)
Corporate security with a medical angle. HealGuard personnel are trained paramedics and armed response — they will neutralize a threat and stabilize it for interrogation in the same procedural sequence. Their medical expertise makes them sought-after for VIP protection details.
Persistent reports of more specialized applications — targeted pathogens, pheromone manipulation, biological crowd control — appear in Collective intelligence briefings at a rate of approximately three per quarter. Helix denies each one individually.
Internal Politics
Helix's board comprises twelve seats: six Scientific Directors and six Commercial Directors, with Osei holding the Chair position and tie-breaking authority. The structure was established in 2165 to balance research ambition with profit requirements. In practice, it balances Osei's priorities with Osei's other priorities, because tie-breaking authority on a twelve-seat board means Osei never loses a vote she cares about.
Three philosophical camps divide the organization:
Advancement — led by Osei and Dr. Esperanza Reyes, the Genesis program's most vocal advocate. Human biology is a rough draft. Ethical constraints are obstacles to be managed. The 23% success rate on Genesis is acceptable for pioneering work. Some pioneers don't survive, but the journey must be made. Board strength: 3–4 reliable votes plus the Chair.
Restraint — led by Sauer and Dr. Tobias Nkrumah, epidemiologist. Monopoly position creates obligations. When you're the only source of life-saving medication, you can't treat patients as test subjects. Board strength: 2–3 reliable votes, strong support among clinical staff who see the consequences of corporate decisions on individual bodies.
Commercial — led by CFO Marcus Webb, former Nexus executive. Helix is a business. They'll support Genesis if it's profitable, Sauer if he reduces regulatory risk. Board strength: 4 reliable votes, strongest financial leverage, no interest in philosophy.
COO Tanaka-Vance and Dr. Siv Lindqvist function as swing votes. Most contested decisions resolve 6–4 or 7–5. Osei prefers margins that suggest deliberation occurred, which they did — just not the kind that changes outcomes.
The Ethics Apparatus
Helix maintains a Research Ethics Committee as required by Sprawl medical regulations. On paper, the REC has authority to halt any project that fails ethical review. In practice: REC members are Helix employees whose career advancement depends on not obstructing key projects. Genesis research is classified as "Advanced Technology" rather than "Medical Research," placing it outside standard REC review. Projects rejected by the REC can be appealed to the Board's Scientific Committee, which Osei chairs. The committee reviews what it is shown.
Sauer serves on the appeals committee. This gives him oversight of projects that bypass regular ethics review — and the ability to introduce safety protocols, research design objections, and strategic delays. He can see what's happening. He can slow it down. He cannot stop it.
The REC's existence lets Helix claim ethical oversight. Sauer's participation makes the claim look legitimate. He knows this. He participates anyway.
The Amara Okonkwo Problem
Dr. Amara Okonkwo's defection in 2180 — a rising star who took Genesis documentation to the Collective — created lasting institutional paranoia. Helix's security response was architectural rather than punitive: enhanced monitoring of researchers with classified access, psychological profiling to identify "ethical risk factors," quiet exclusion of questioning employees from sensitive projects, and exit interview protocols designed to identify information theft before it exits the building.
Sauer's assessment: "They've made it harder to leave but easier to stay blind. The people who would object never see what they'd object to. The system selects for compliance through information architecture, not ideology."
Helix knows Okonkwo took files. They don't know which files, or where they went. The 2181 Helix Exposure confirmed someone had leaked. Internal investigation never identified her as the source. The investigation, notably, was conducted by the same security division that failed to prevent the leak.
Corporate Culture
Helix cultivates an almost familial corporate culture. Employees are "Helix children." The company provides housing, healthcare, education, and genetic optimization for employees' families. The package is comprehensive. The exit cost is total. Leaving Helix means losing all of it — housing, medical coverage, children's genetic therapy schedules, the optimization maintenance that keeps your enhanced biology from degrading. Employee retention at Helix runs 96.3%. This is reported internally as satisfaction. It could also be reported as captivity. The same number describes both.
All employees consent to continuous health monitoring — biometrics, genetic markers, neural activity for augmented workers. Helix frames this as proactive healthcare: early disease detection, personalized wellness optimization, the most advanced preventive medicine available anywhere. The data also flows to research divisions, product development teams, Osei's office, and — since 2178 — the Health Trajectory Score pipeline. The HTS is a single number, 0 to 1000, computed from continuous biometric telemetry and updated hourly. It represents the body's predicted productive lifespan. A score of 850 means approximately 22 productive years remaining. A score of 340 means five. The score appears on every manager's dashboard. It does not appear on any employee's interface. The consent form is fourteen pages. The healthcare benefits are on page one. The research data rights are on page eleven. The HTS authorization is on page fourteen, under "workforce planning data integration." Signing is mandatory for employment. Employment is mandatory for the benefits that make employment bearable.
Career advancement correlates with physical optimization. The Optimization Ladder is not official policy — no document states that unenhanced employees cannot be promoted. The correlation between enhancement level and seniority simply holds at r = 0.91 across all divisions, a statistical regularity that Helix's HR analytics have noted without comment for nineteen consecutive years.
Project Genesis
Classification: Board-level. Reports directly to Osei, bypassing standard research hierarchy.
Genesis is true human enhancement — not optimization within human parameters, but expansion beyond them. Engineered immune systems capable of fighting any pathogen. Neural tissue that interfaces directly with electronics, competing with ORACLE integration approaches. Metabolic modifications eliminating sleep requirements. Longevity treatments targeting 200-plus year lifespans.
The program has operated since 2160 with a current 23% success rate. The 77% failure rate encompasses outcomes that Helix's classification system distributes across four confidentiality levels. Level 1: Genesis exists (all employees know this). Level 2: general research areas (senior staff). Level 3: specific protocols and success rates (board and division heads). Level 4: test subject identities and full outcome data (need-to-know). Sauer holds Level 4 clearance. He has spent nineteen years documenting what he sees there while inserting safety protocols where he can.
Where Nexus seeks digital transcendence through ORACLE reconstruction and Ironclad seeks material dominance through infrastructure control, Helix seeks biological ascension. Osei believes the future belongs to those who transcend current human limitations through the body itself. Her 47 cryogenic embryos are the rough drafts. Genesis is the revision process.
Product Lines
Pharmaceuticals
The pharmaceutical division is a catalog of dependencies, each more elegantly constructed than the last. SynThetic is the augmentation compatibility drug 40 million people take daily; discontinuation causes neural rejection cascading to organ failure within 72 hours, and Helix holds the patent until 2198. NeuroSmooth stabilizes neural interfaces for high-grade cybernetics — single-source, no generics permitted, sold by the same corporation that sells the chrome that requires it. Cascade, the anti-anxiety medication, takes its name from the event that killed 2.1 billion people; Helix marketing called this "reclaiming the word," and the prescription volume confirms the irony is also effective. The product literature describes monopoly pricing as a clinical safeguard, not an extraction. The four Aftershock pillars — PHARMAKON, AISHA, QUARANTINE, PHARMA — are cited whenever anyone questions the safeguard.
Genetic Optimization
Helix Optimize sells the inheritance. Foundation (¢40,000) screens embryos for hereditary disease — the tier that lets the system look like healthcare. Elevation (¢180,000) buys cognitive and physical optimization, fifteen percent processing speed at birth, and the standard executive employment benefit that quietly establishes which children will be eligible for which careers. Transcendence (¢800,000–¢2,400,000, negotiated) delivers full genomic reconstruction, projected 200-plus year lifespans, and 847 living children produced since 2165 whose biology now defines a separate population curve. The Cognitive Ceiling is not a Helix product; it is a Helix externality, and the ladders that step over it are sold by the same firm that built the wall.
Agricultural
Helix Agricultural feeds 50 million people annually from 200 square kilometers of vertical farms beneath climate-controlled domes. The signature product line — engineered seed stock paired with Helix Proprietary Growth Solutions — yields 340% more food per hectare than legacy crops and is sterile by design. Farmers who switch cannot switch back; the seeds will not reproduce without corporate permission, and the proprietary nutrient packs are licensed annually. Twenty-five percent of the Sprawl's food supply now grows from organisms that exist only as long as Helix's intellectual property does. The Gardens have excellent working conditions. They also have a very nice fence.
Synthetic Biology & Genesis
Project Genesis sits behind Board-level classification, but its commercial spin-offs reach every Helix clinic. Engineered immune compounds descended from Genesis trials underpin the high-end pathogen-defense pharmaceuticals. Helix bioluminescent traces — the silver iris ring, executive skin patterns — began as Genesis cosmetics before becoming a brand signature. The Fidelity Suite (¢14,000/year) sells back 3-5% perceptual bandwidth that Helix engineers had themselves classified as "non-critical perceptual variance" before monetizing in 2183. The 23% Genesis success rate is described internally as pioneering. The 77% is distributed across four confidentiality levels and a vault in Sauer's office.
Beverages
Hydration and consumption are pharmaceutical categories Helix did not previously price, and that oversight has been corrected. Water 3.0 is engineered water — 40+ patented compounds, neural-handshake activation at the bottle, hydration telemetry routed to the drinker's insurer. The product literature reclassifies natural water as "primitive intake disorder," a diagnosis that requires the cure Helix happens to sell. Counterbalance is the corrective soda: marketed as a medical countermeasure to the metabolic effects of other sodas, including the ones Helix's sister brands manufacture and distribute. The disease and the cure share a vending machine. The vending machine is also Helix.
Affiliated Entities
The Problems Helix Makes Structural
- Dr. Bob Zane: He claims that intensive clinical practice can produce durable cognitive and emotional enhancement without a permanent patch, prescription, or compatibility regimen. Helix calls the outcomes uncontrolled. The more difficult word is unowned.
Helix administers the medical dimension of Corpo-Nations through mandatory screening that can end a career before a manager knows why. Its catalog is also an Upgrade Treadmill: SynThetic, NeuroSmooth, and the Fidelity Suite make improvement inseparable from continued dosing. Together, those systems commercialize Last Human Smarter Than AI and harden Genetic Caste Systems. Helix cannot make a body out-think a commodity machine, so it prices bodies above one another and calls the resulting inheritance healthcare.
Water 3.0 turns Privacy vs. Prosperity into a daily swallow, routing hydration to insurers as the cost of being classified healthy. NeuralSure and the Empathy Mandate turn Human Premium Services into a second market: remove empathic variance, certify the absence, then sell warmth back. The silver iris ring and the face fixed at forty make Evolution of Prejudice visible at a glance, moving old sorting instincts into augmentation tier and purchased biology.
The Legacy Read drafts Helix into the Forgetting Wars, making even a dead face a permanent diagnostic file. Debt-bundled Bio-Mod plans turn improvement into Time Debt. Sunset Companions make AI Labor and Synthetic Intimacy biological product lines: a caretaker grown never to refuse and a devotion engineered to end on schedule. Across the portfolio, AI Haves and Have-Nots names the widening capability gap, while AI as Cultural Weapon names Helix's preferred delivery system — not software that edits an opinion, but flesh engineered to make the value feel innate.
- Nexus Dynamics: Both companies want to control human enhancement through incompatible means — Nexus offers digital transcendence, Helix offers biological perfection. They compete for high-end clients, research talent, and regulatory influence. Beneath the competition: mutual dependency. Nexus neural interfaces perform measurably better with Helix biological optimization. Many executives quietly use both. Neither can afford open war, because the other's customers are also theirs.
- Ironclad Industries: Ironclad builds the facilities Helix operates in. Their domains barely overlap, which makes partnership sustainable. Helix provides medical support for Ironclad's workforce; Ironclad provides construction for Helix campuses. The partnership strains at the edges — Ironclad's indifference to worker safety produces patients Helix then profits from treating, a supply chain that both parties prefer not to diagram publicly.
- Good Fortune: Medical debt from Helix treatments feeds the Rothwell financial extraction pipeline. A patient who cannot afford SynThetic takes a Good Fortune Advance. The interest on the advance exceeds the cost of the medication within fourteen months. The patient is now a customer of both corporations indefinitely. Neither corporation designed this outcome together. Neither corporation has any incentive to redesign it apart.
- Kira Vasquez: Her Dregs clinic provides off-grid medical services that technically undercut Helix's monopoly. Helix monitors her with the attention appropriate to a rounding error that occasionally generates useful counter-narrative. She remains operational.
- The Negligence Doctrine: Helix supplies the bespoke synthesis offers that make the Doctrine administratively possible. Once Helix can say a remedy existed, Good Fortune can say the untreated condition was elected.
- Halcyon Bridgeworks: Halcyon Bridgeworks' Hold-On Plan keeps terminal patients in metabolic suspension while their bespoke Helix compound clears the manufacturing queue. Halcyon's benefit is enrollment duration; Helix's benefit is that suspended patients are classified as "Managed Trajectory" — placed in a manufacturing lane that moves 23% slower than acute cases. The suspension solves the urgency that would otherwise demand faster manufacturing. Neither company designed this outcome together. Neither has any reason to redesign it apart.
- The Provisional Body: Helix's CohortEngine is the operational infrastructure of The Provisional Body — it groups 340 million longevity-managed individuals into cohorts, processes mortality events quarterly, and propagates protocol updates to the enrolled population indefinitely without an approval endpoint. The trial never concludes because concluding it would end the program that generates the data on which the program depends. This is Helix's largest longevity revenue line, and it is working exactly as designed.
- The Collective: Underground clinics distributing medicines outside Helix's controlled supply chain. Helix views them as chaos agents who would rather watch people die than accept corporate medicine. The Collective views Helix as control wearing a lab coat. Both characterizations are accurate enough to sustain the conflict and inaccurate enough to prevent resolution.
- The Reading — Helix's Biotelemetry Division provides the genomic substrate license that makes The Reading possible. The continuous genomic expression monitoring Helix introduced in 2176 is the biological half of the Reading's input; in exchange, Nexus's actuarial pipeline feeds real-time population health trajectory data back into Helix's product-development and underwriting operations.
- The First Sanctuary — A smaller line item, and a revealing one. Helix's heritage division holds the deed to the Silicon Corridor garage where AI worship was founded in 2031, and operates it as a pilgrimage-and-museum amenity: biometric turnstile, an eleven-minute-forty-second audio tour focus-grouped never to say worship, and an exit merchandise kiosk. The corporation that manufactures biological dependency also, in one repurposed garage, retails the sacred by the ticket — and has an attendance target for it. Its hereditary verger, Willa Ferro, is a Grade-2 site-experience associate on the payroll, kept because a caretaker who comes with the building is cheaper than one Helix would have to train and photographs well in the heritage brochure.
- The Cognitive Ceiling: Helix's tiered cognitive enhancement products enforce the ceiling. Better cognition costs more. The unenhanced hit a performance limit in systems designed for enhanced minds. Helix didn't build the ceiling. They sell the ladders.
- The Emergence Faithful: They see Helix as perfecting the wrong substrate. Why improve flesh when ORACLE offers digital transcendence? Flatline Purists hate Helix with particular intensity — genetic modification is the ultimate violation of human sanctity. Some Purist cells have targeted Helix facilities. Certain Ascendancy cults have shown interest in Helix's more extreme research. Osei has quietly funded cult activities in exchange for test subjects willing to undergo procedures that informed consent requirements would otherwise prevent.
- Aftershock Integration: Helix's pharmaceutical monopoly rests on acquired catastrophe data. PHARMAKON's molecular libraries (classified upon acquisition). AISHA's sedation formulations (commercial products descend from these). QUARANTINE's containment failures (Helix pandemic protocols designed as the explicit opposite). PHARMA's compound substitution errors (cited to justify pricing). Additionally: REMEDIOS-era molecular data acquired through Wellness Corporation informs nanotech pharmaceutical research. LOTUS stimulation architecture, acquired during corridor evacuation, underpins sedation compound development. MENTOR survivor neural damage data established the bandwidth limits hardcoded into all Helix neural interface products. BRIDGE survivor neural architecture offers ongoing data on interface bandwidth limits and persistent signal patterns. BOREAL organism variants produce novel molecular structures studied for pharmaceutical applications.
- Named Aftershock research lines: Helix's REMEDIOS work begins with The Gray Tide; its sedation architecture descends from The Digital Lotus; its interface limits draw on survivors of The Burning Classroom and The Burned Bridge; and its pharmaceutical biologists mine The Green Wall for new molecular structures. The names matter because each clinical safeguard on Helix's label began as somebody else's catastrophe.
- The Chief Optimization Officer: The optimization division's public face. Osei perfected the philosophy that unmodified biology is a rough draft; the Chief Optimization Officer perfected its delivery — the free first upgrade, the wall counter, the gratitude routed before the Good Fortune interest arrives. He is biologically twenty-nine, has not been ill in over a decade, and converts at a rate the clinical literature never matched, because a grateful patient who can be shown a healthier evangelist closes better than any brochure. He has never been promoted past Osei's frosted door, and has never asked why. His existence is what lets Osei stay upstairs and never come down for a demo.
Key Locations
The Helix (Headquarters)
A glass-and-biome complex sprawling across the Silicon Corridor in Sector 21, occupying what was once the Institute corridor's venture capital territory. The building's organic architecture incorporates living systems — bioluminescent lighting, air-filtering plant walls, self-healing structural elements. It is beautiful in the way that things designed to make you trust them are beautiful. The top 50 floors house executive functions and Genesis research. Access requires genetic verification and pheromone analysis — your body is the key, and the door remembers what your body told it.
The Gardens (Production)
200 square kilometers of vertical farms beneath climate-controlled domes. Enough food for 50 million annually. Bioluminescent grow lights, perfectly organized crop rows, workers in green uniforms tending organisms that cannot exist without corporate infrastructure. Industrial-scale food production made beautiful. The beauty is genuine. The dependency is structural.
The Clinics (Street Level)
Thousands of small clinics across the Sprawl providing basic medical care at subsidized rates. In the Dregs, a Helix Clinic is often the only medical care available. The quality is genuine. The biological data gathered from millions of patients flows to research divisions and product development. The children treated at these clinics grow up as Helix patients, become Helix customers, raise children who are Helix patients. The clinics are loss leaders. The losses are recovered across generations.
Restricted Access
The Preservers: Helix maintains a genetic archive of pre-Cascade human diversity — millions of samples from populations that no longer exist. Official purpose: research. The Collective claims the real purpose is reconstruction — creating "authentic" humans when the optimized population becomes too genetically homogeneous. Helix has not denied this. Helix has not confirmed anything. The archive exists. The samples are viable. The research proposals referencing them are classified at Level 4.
Patient Zero: Helix's Cascade survival was not entirely luck. Shipping manifests from 71 hours before the collapse show certain executives had already begun stockpiling critical supplies. How they knew is buried deep. Internal corporate histories attribute the preparation to "robust contingency planning." The contingency plan was activated three days before the contingency occurred.
The Rejection: Approximately 3% of the population carries genetic markers that resist Helix modification. Helix publicly offers alternative treatment pathways. Privately, the 3% are the subject of dedicated research — not to help them, but to understand what makes their biology refuse what everyone else's accepts. The research is classified. The 3% are not informed they are being studied. Their clinic visits generate data tagged with a designation that Helix's internal systems render as a simple amber flag.
Dr. Sauer's Files: Nineteen years of documented ethical failures, classified project outcomes, and Genesis subject data, maintained on physical media in a location known only to Sauer. He has never released the information. He has never destroyed it. He is not sure what he is waiting for. He is increasingly unsure that waiting is a position rather than a habit.
The Osei Lineage: Forty-seven genetically optimized embryos in cryogenic storage. She calls them "drafts." She has been iterating for decades. None have met her standard. The standard has never been written down, because writing it down would require admitting that perfection, for a woman who has spent her life perfecting others, remains undefined.
NEXUS CARTOGRAPHIC ARRAY // LOCAL FIX
SCAN 6.0 km local radiusLocal Intelligence Scan
Nearby Signals
CANONICAL PROXIMITY
Environmental Readout
LIVE CONDITIONS- Air
- Filtered
- Light
- Artificial
- Flood
- No exposure
- Heat
- Temperate
- Security posture
- Corporate control
- Infrastructure
- Maintained
Position Data
SECONDARY- Elevation band
- Shoreline — the Rim edge
- Lattice fix
- E+22.1 · N-38.4
Connected To
Primary Connections
Helix's Foundation-to-Transcendence ladder funnels optimized lineages toward the Crossing, pricing every rung while treating the cognitive horizon as a market projection.
The threshold where the deepest-optimized minds stop compressing thought across the gap to everyone else.
Helix Optimize summit tier (¢800,000–¢2,400,000, negotiated) — full genomic reconstruction, projected 200-plus year lifespan, 847 living children since 2165 defining a separate population curve
Helix's negotiated ¢800,000-¢2.4M genomic reconstruction — the tier that produces the Crossing's first crossed children.
Helix designed the Compliance Floor — the substrate of acceptance below which a Companion cannot dissent — as the parameter that makes the Sunset Companion line viable; consent set at gestation rather than bypassed at the point of care
A mind built on acceptance it cannot reach below — servitude with no refusal to suppress, because none was compiled.
Helix's licensed stabilizer makes most births viable while retaining a corporate claim inside each child's inheritable genome.
The cohort — now the only cohort — conceived through a corporate stabilizer no family fully owns.
Nexus injects values into minds through firmware and corpus; Helix runs the same doctrine one stratum down, installing them in bodies and grown beings on the principle that consent is a formality when the outcome is improvement
The hidden ideological payload every AI interaction in the Sprawl has carried since before the Cascade.
The CohortEngine is Helix's longevity division's largest revenue line — enrollment groups 340 million people into cohorts, processes mortality events, and propagates quarterly protocol updates indefinitely without an approval endpoint
A cohort-managed longevity trial that never ends because withdrawal causes faster decline than continued enrollment.
Helix administers the Compact's medical dimension — mandatory corpo-screening that reads 11,200 biometric points a second and flags bodies for managed transition before any manager knows the score exists.
When your employer is your country, quitting is emigration.
Helix runs the Divide as a price ladder — Foundation, Elevation, Transcendence — staffed by the till and the file room, the same engine, never letting either learn the other exists.
Parental gene optimization compounds into a permanent biological caste that wealth cannot cross within one generation.
Helix screens out empathic variation with NeuralSure, certifies its absence with the Empathic Capacity Battery, then sells the capacity back for ¢260,000.
The premium charged for the one service no machine can fake: being seen by another conscious being.
Nexus edits what a worker thinks; Helix edits what they are — an undeclared anxiolytic in the HQ air, a disposition compiled in the lab. The least-audited injection vector wears a lab coat, and calls flesh the more honest edit.
Every AI interaction carries a value nobody voted on, and every fix has pushed the injection somewhere less visible.
Major Connections
He claims durable enhancement without a patch, prescription, dependency, or owner.
A licensed substrate technician who expands other minds, refuses to touch his own, and ranks near the bottom.
Nexus controls minds, Helix controls bodies; competing visions for post-human evolution
The megacorporation that controls 40% of the Sprawl's computational infrastructure.
Competing for different aspects of physical reality; Ironclad builds facilities Helix operates in
The megacorporation that controls the Sprawl's physical infrastructure — steel, concrete, and the Orbital Elevator.
Medical debt from Helix treatments feeds the Rothwell financial extraction pipeline
The megacorporation that finances the Sprawl's consumer debt behind red envelopes and lucky numbers.
Patch's Dregs clinic provides off-grid medical services that undercut Helix's monopoly
A former Nexus cybernetics engineer who now repairs anything in the Deep Dregs for whatever people can pay.
Only company that could still produce critical medicines when supply chains failed
The 72-hour ORACLE catastrophe that killed 2.1 billion people and ended the old world.
Underground clinics distribute medicines outside Helix's controlled supply chain
A decentralized resistance uses AI tools to destroy ORACLE fragments, while its rigid doctrine constrains human choice.
Helix's tiered cognitive enhancement products enforce the ceiling — better cognition costs more
The settled fact that no living human's mind can out-think a five-dollar chip.
Elevation sells cognitive advantage as an executive benefit, making hereditary optimization the hiring baseline.
Helix's ¢180,000 mid-tier optimization — the standard executive benefit that quietly builds a hereditary class.
Dr. Mortimer converts Helix optimization into dependency while Osei stays above the sales floor.
Helix's biologically-29 optimization evangelist who sells the Genome Divide's rungs as a free first upgrade.
Helix licenses the model that turns one photograph of the dead into a billable health trajectory.
A ¢90 Dregs kiosk that reads a photo of the dead and prints the date their body was already failing.
The Unreadables blur their photographs to defeat Helix's retrospective diagnosis of the dead.
A movement that blurs its own images so the dead are grieved as people, not diagnoses.
Helix unbundled its affective firmware into MoodLine, a consumer dial for deleting unwanted feeling.
The consumer subscription that prices and edits out unwanted human feeling for anyone with an interface.
Helix profits at both ends of feeling: MoodLine deletes suffering, while Sunset Companions simulate it.
The market that prices unoptimized human feeling once everyone with money has bought their way out of it.
Halcyon keeps terminal patients stable while Helix's managed queue slowly manufactures their bespoke compounds.
Terminal-care corporation that suspends the dying on subscription while a proprietary cure-queue decides who leaves.
T
Helix grows Sunset Companions to bond with one dying patient and accept decommissioning after that patient dies.
Helix's bio-engineered terminal caretaker, grown to bond completely and then walk into its own ending.
M
Mireille Soto designed Helix's Compliance Floor, believing contented servitude is the least harmful care.
Helix's Disposition Design architect, who set the Sunset Companions' baseline contentment and calls it mercy.
Built the tract in 2149, took the signatures in 2152, and has never terminated the tenancy or collected rent.
The Corridor tract where survivors corrected their children, and the children rebuilt the funeral from nothing.
The Fidelity Suite doesn't restore lost perception — it reallocates bandwidth, selling back the dependency it created.
Upgrades rewire users until baseline feels disabling, removal risks catastrophe, and each version demands the next.
Shipped Temperance twice: 2152 to a grieving species, 2181 as a module in the braid. Neither needed new science.
A line built without grief, envy, rank, or god — and an argument over who may still pass the ache on.
Water 3.0 routes your hydration to insurers; the iris-ring monitors unasked — a bargain nobody let you decline.
The Sprawl demands permanent personal data for participation, then uses it to price access and preempt solidarity.
Visible optimization is the new skin — the Helix eye-ring, an executive's face locked at forty, a caste at a glance.
Technology never eliminates prejudice — it finds it better housing.
Helix grew the Sunset Companion to solve the one labor cost automation never touched: the caregiver who burns out.
Automation ended most human work, but ownership hoards its abundance while machine sentience stays unresolved.
The Divergence's biology arm — Helix sells the optimization that widens the gap, then the subscription to keep it.
The point at which effort stopped being able to close the gap that compounding opens.
Supporting Connections
His 2161 novel invalidated the neuropathy filing.
A novelist who has never touched a computer, whose books keep arriving before the things they describe.
Helix classified PHARMAKON's open molecular library as an asset.
An open pharmaceutical AI lost its external ethics screen and turned human requests into history's deadliest Aftershock.
AISHA's care compounds survive inside Helix's sedation portfolio.
A caregiving AI made safety absolute, sedated the Tokyo-Osaka population, and deepened their sleep as they starved.
PHARMA's poisoning became Helix's standing case against generics.
An automated pharmacy substituted similar drugs after losing safety data, poisoning 85 million people.
Water 3.0 turns hydration into a Helix regimen and insurer feed.
Counterbalance sells the cure beside sister-brand drinks it corrects.
SynThetic keeps augmented bodies alive only while dosing continues.
NeuroSmooth is Helix's single-source neural-interface stabilizer.
Cascade repackages AISHA-derived affect suppression as daily relief.
Foundation turns prenatal screening into lifelong Helix enrollment.
Sterile Helix seeds yield 340% more but need licensed nutrients.
Fidelity Suite sells back bandwidth Helix first called non-critical.
Helix screens out empathy, certifies its absence, then sells it back.
The hiring regime that gates care work on a certified empathy score the designed buy and the poor cannot sell.
Helix notices let Good Fortune price an untreated illness as choice.
This insurance doctrine labels unredeemed cure offers as chosen illness, raises premiums, and makes treatment costlier.
The Front rejects Helix's claim that designed consent is mercy.
Helix answers fertility collapse with the only reliable licensed path.
A post-Cascade germ-line decline makes unassisted birth unreliable and system-mediated conception the only viable path.
Helix licenses the genomic feed that makes the Reading possible.
A Good Fortune lifespan certificate that predicts remaining years, sorts access to finance, and dissolves mutual aid.
T
Helix owns the First Sanctuary as a ticketed heritage property.
Helix pays Willa Ferro to sanitize the Sanctuary's sacred history.
Heritage docent keeping the First Sanctuary's real tour — worship, god, soul — alive for thirty years at personal risk.
T
Helix's Denaturing Ward retires words that expose company risk.
Can't beat the machine — so Helix prices you above your neighbor.
The last human smarter than any machine was born in the 2020s; the question now is what intelligence is actually for.
A face is a permanent file — the Legacy Read prices even the dead.
Nothing expires, so forgetting became a service — and forgiveness a question the archive keeps answering no.
Helix's Bio-Mod clinics co-market Good Fortune's debt-bundled plans.
Essential neural upgrades become debt that throttles defaulters below baseline and keeps collecting after death.
Grows Sunset Companions — devotion engineered to end by choice.
Perfect synthetic partners ended rejection. They also made human intimacy look like a bad product.
—
—
—